An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

Positive results mark an important step forward in efforts to develop effective treatments for children with drug-resistant TB COPENHAGEN, Denmark, Nov. 19, 2025 /PRNewswire/ -- New interim data from ...

This post by Meghan Werft was originally published on Global Citizen on January 6, 2016. After “pharma-bro” Martin Shkreli hiked drugs prices to ridiculous amounts last year, it’s nice to hear about a ...

LONDON (Reuters) - Multi-drug resistant strains of tuberculosis (TB) could become dominant forms of the disease in the next few decades, adding heavy financial and medical burdens to already ...

This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

Patients who have drug-resistant tuberculosis (TB) have a similar microbiological response to bedaquiline-based second-line medications as patients with drug-sensitive TB taking first-line regimens, ...

CANCUN, Mexico (Reuters) - Health experts on Thursday called for more research funding to develop better diagnostic tests, vaccines and drugs for tuberculosis, which killed 1.8 million people around ...